USP19 and lung cancer: In our study, the opposing roles of USP19-ER and USP19-CY in TGF-β/SMAD signaling caused USP19-CY to stimulate and USP19-ER to inhibit TGF-β-induced biological processes in breast and lung cancer, including TGF-β-induced EMT and cell migration.